This site looks better in landscape mode
Skip to content
AKL Therapeutics
Radically improving healthspan with a novel multifactorial approach to osteoarthritis
Developing a novel therapeutic for inflammatory diseases with a high unmet need
Developing a novel therapeutic for inflammatory diseases with a high unmet need
Over 2%
The burden to society of osteoarthritis in developed counties is more than 2% annual GDP
